Ali Eslamifar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Eslamifar has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Fattah Sotoodehnejadnematalahi
Department of Biology, SR.C., Islamic Azad University, Tehran, Iran
3 shared publications - Masoomeh Shams-Ghahfarokhi
Department of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3 shared publications - Mehdi Razzaghi-Abyaneh
Department of Mycology, Pasteur Institute of Iran, Tehran, Iran
3 shared publications - Mohammadhassan Gholami-Shabani
Pasteur Institute of Iran
3 shared publications - Ahmad Teymoornejad
Obesity Treatment Center Faculty of Medicine Shahed University Tehran Islamic Republic of Iran
1 shared publication - Alireza Khalaj
Obesity Treatment Center, Department of Surgery, Shahed University, Tehran, Iran
1 shared publication
Latest Publications
- 14 February 2022
- Published by Springer Nature in Journal of Cluster Science
- Vol. 34 (1) , 501-516
Platinum Nanoparticles as Potent Anticancer and Antimicrobial Agent: Green Synthesis, Physical Characterization, and In-Vitro Biological Activity
- 14 February 2022
- Published by Springer Nature in Journal of Cluster Science
- Vol. 34 (1) , 501-516
Platinum Nanoparticles as Potent Anticancer and Antimicrobial Agent: Green Synthesis, Physical Characterization, and In-Vitro Biological Activity
- Open Access
- 23 November 2021
- Published by Institution of Engineering and Technology (IET) in IET Nanobiotechnology
- Vol. 16 (1) , 1-13
Physicochemical properties, anticancer and antimicrobial activities of metallic nanoparticles green synthesized by Aspergillus kambarensis
In the present study, metal and metal oxide nanoparticles were successfully synthesized using Aspergillus kambarensis . UV–Vis spectroscopy showed maximum absorbance of 417 nm for silver (AgNPs), 542 nm for gold (AuNPs), 582 nm for copper (CuNPs) and 367 nm for zinc oxide (ZnONPs) nanoparticles. Fourier transform infrared spectroscopy indicated the presence of various mycochemicals with diverse functional groups in the fungal cell‐free filtrate. Transmission electron microscopy revealed mono and poly dispersed particles with an estimate size of 50 nm and different shapes for synthesized manufacture metallic nanoparticles (MNPs. Dynamic light scattering confirmed that MNPs were dispersed in the size range less than 50 nm. Zeta potential analysis showed values of −41.32 mV (AgNPs), −41.26 mV (AuNPs), −34.74 mV (CuNPs) and 33.72 mV (ZnONPs). X‐ray diffraction analysis demonstrated crystalline nature for MNPs. All the synthesized MNPs except AuNPs showed strong antifungal and antibacterial activity in disc diffusion assay with growth inhibition zones of 13.1–44.2 mm as well as anticancer activity against HepG‐2 cancer cell line with IC 50 in the range of 62.01–77.03 µg/ml. Taken together, the results show that biologically active MNPs synthesized by A. kambarensis for the first time could be considered as promising antimicrobial and anticancer agents for biomedical applications.
- 23 November 2021
- Published by Institution of Engineering and Technology (IET) in IET Nanobiotechnology
- Vol. 16 (1) , 1-13
Open AccessPhysicochemical properties, anticancer and antimicrobial activities of metallic nanoparticles green synthesized by Aspergillus kambarensis
In the present study, metal and metal oxide nanoparticles were successfully synthesized using Aspergillus kambarensis . UV–Vis spectroscopy showed maximum absorbance of 417 nm for silver (AgNPs), 542 nm for gold (AuNPs), 582 nm for copper (CuNPs) and 367 nm for zinc oxide (ZnONPs) nanoparticles. Fourier transform infrared spectroscopy indicated the presence of various mycochemicals with diverse functional groups in the fungal cell‐free filtrate. Transmission electron microscopy revealed mono and poly dispersed particles with an estimate size of 50 nm and different shapes for synthesized manufacture metallic nanoparticles (MNPs. Dynamic light scattering confirmed that MNPs were dispersed in the size range less than 50 nm. Zeta potential analysis showed values of −41.32 mV (AgNPs), −41.26 mV (AuNPs), −34.74 mV (CuNPs) and 33.72 mV (ZnONPs). X‐ray diffraction analysis demonstrated crystalline nature for MNPs. All the synthesized MNPs except AuNPs showed strong antifungal and antibacterial activity in disc diffusion assay with growth inhibition zones of 13.1–44.2 mm as well as anticancer activity against HepG‐2 cancer cell line with IC 50 in the range of 62.01–77.03 µg/ml. Taken together, the results show that biologically active MNPs synthesized by A. kambarensis for the first time could be considered as promising antimicrobial and anticancer agents for biomedical applications.
- Open Access
- 22 October 2021
- Published by Wiley in Journal of Nanomaterials
- Vol. 2021, 1-12
Mycosynthesis and Physicochemical Characterization of Vanadium Oxide Nanoparticles Using the Cell-Free Filtrate of Fusarium oxysporum and Evaluation of Their Cytotoxic and Antifungal Activities
Green nanotechnology is an expanding branch of knowledge in relation to producing efficient antifungal compounds with potential applications as nanomedicines. The aim of the current investigation was to mycosynthesize functional vanadium oxide nanoparticles (V2O5NPs) by Fusarium oxysporum cell-free filtrate using ammonium metavanadate (NH4VO3) as the substrate. Various spectrometric methods and electron microscopy were used to confirm the production of mycosynthesized V2O5NPs. FESEM and TEM images showed that V2O5NPs were in the size ranging from 10 to 20 nm in a spherical shape. The XRD pattern revealed the presence of crystalline, dominantly spherical V2O5NPs in the sample with a size ranging from 10 to 20 nm. The XRD peaks 15.2, 20.1, 21.6, 26.1, 30.9, 32.2, 33.1, 34.2, 41.0, 41.8, 45.3, 47.2, 48.6, 51.1, 51.9, 55.4, and 58.8 can be assigned to the plane of vanadium crystals and indicate that the V2O5NPs were face-centered, cubic, and crystalline in nature. The FTIR results showed the presence of some biomolecules in fungal cell-free filtrate that act as a bioreducing and capping agent for V2O5NP mycosynthesis. DLS showed that the size of V2O5NPs was 10-20 nm. Zeta potential showed −35.09 mV for V2O5NPs with a single peak. Study of antifungal activity of V2O5NPs against various pathogenic fungi in concentrations of 5, 25, 50, and 100 μg/mL showed that V2O5NPs strongly inhibited both mycelium growth (20.3 to 67.3%) and spore germination (64.8 to 89.9%) dose-dependently. V2O5NPs showed strong cytotoxicity against breast cancer cell-line MCF-7 with an value of 55.89 μg/mL. Microscopy images showed morphological changes and reduction of cancer cell populations in V2O5NP-treated MCF-7 cell-line. Taken together, our results demonstrated that bioactive V2O5NPs successfully synthesized by F. oxysporum could be considered a potential candidate in drug development against life-threatening fungal pathogens and as a feasible anticancer agent.
- 22 October 2021
- Published by Wiley in Journal of Nanomaterials
- Vol. 2021, 1-12
Open AccessMycosynthesis and Physicochemical Characterization of Vanadium Oxide Nanoparticles Using the Cell-Free Filtrate of Fusarium oxysporum and Evaluation of Their Cytotoxic and Antifungal Activities
Green nanotechnology is an expanding branch of knowledge in relation to producing efficient antifungal compounds with potential applications as nanomedicines. The aim of the current investigation was to mycosynthesize functional vanadium oxide nanoparticles (V2O5NPs) by Fusarium oxysporum cell-free filtrate using ammonium metavanadate (NH4VO3) as the substrate. Various spectrometric methods and electron microscopy were used to confirm the production of mycosynthesized V2O5NPs. FESEM and TEM images showed that V2O5NPs were in the size ranging from 10 to 20 nm in a spherical shape. The XRD pattern revealed the presence of crystalline, dominantly spherical V2O5NPs in the sample with a size ranging from 10 to 20 nm. The XRD peaks 15.2, 20.1, 21.6, 26.1, 30.9, 32.2, 33.1, 34.2, 41.0, 41.8, 45.3, 47.2, 48.6, 51.1, 51.9, 55.4, and 58.8 can be assigned to the plane of vanadium crystals and indicate that the V2O5NPs were face-centered, cubic, and crystalline in nature. The FTIR results showed the presence of some biomolecules in fungal cell-free filtrate that act as a bioreducing and capping agent for V2O5NP mycosynthesis. DLS showed that the size of V2O5NPs was 10-20 nm. Zeta potential showed −35.09 mV for V2O5NPs with a single peak. Study of antifungal activity of V2O5NPs against various pathogenic fungi in concentrations of 5, 25, 50, and 100 μg/mL showed that V2O5NPs strongly inhibited both mycelium growth (20.3 to 67.3%) and spore germination (64.8 to 89.9%) dose-dependently. V2O5NPs showed strong cytotoxicity against breast cancer cell-line MCF-7 with an value of 55.89 μg/mL. Microscopy images showed morphological changes and reduction of cancer cell populations in V2O5NP-treated MCF-7 cell-line. Taken together, our results demonstrated that bioactive V2O5NPs successfully synthesized by F. oxysporum could be considered a potential candidate in drug development against life-threatening fungal pathogens and as a feasible anticancer agent.
- Open Access
- 20 January 2016
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 5 (1) , e8
Bariatric Surgery for Morbid Obesity: Tehran Obesity Treatment Study (TOTS) Rationale and Study Design
Obesity is a major health concern in the Middle East and worldwide. It is among the leading causes of morbidity, mortality, health care utilization, and costs. With bariatric surgery proving to be a more effective treatment option for overweight and obesity, the need for systematic assessment of different procedures and their outcomes becomes necessary. These procedures have not yet been described in detail in our region. We aim to undertake a prospective study evaluating and comparing several surgical bariatric procedures in an Iranian population of morbid obese patients presenting to a specialized bariatric center. In order to facilitate and accelerate understanding of obesity and its complications, the Tehran Obesity Treatment Study (TOTS) was planned and developed. This study is a longitudinal prospective cohort study in consecutive patients undergoing bariatric surgery. TOTS investigators use standardized definitions, high-fidelity data collection system, and validated instruments to gather data preoperatively, at the time of surgery, postoperatively, and in longer-term follow-up. This study has recruited 1050 participants as of September 2015 and is ongoing. This study will ensure creation of high-level evidence to enable clinicians to make meaningful evidence-based decisions for patient evaluation, selection for surgery, and follow-up care.
- 20 January 2016
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 5 (1) , e8
Open AccessBariatric Surgery for Morbid Obesity: Tehran Obesity Treatment Study (TOTS) Rationale and Study Design
Obesity is a major health concern in the Middle East and worldwide. It is among the leading causes of morbidity, mortality, health care utilization, and costs. With bariatric surgery proving to be a more effective treatment option for overweight and obesity, the need for systematic assessment of different procedures and their outcomes becomes necessary. These procedures have not yet been described in detail in our region. We aim to undertake a prospective study evaluating and comparing several surgical bariatric procedures in an Iranian population of morbid obese patients presenting to a specialized bariatric center. In order to facilitate and accelerate understanding of obesity and its complications, the Tehran Obesity Treatment Study (TOTS) was planned and developed. This study is a longitudinal prospective cohort study in consecutive patients undergoing bariatric surgery. TOTS investigators use standardized definitions, high-fidelity data collection system, and validated instruments to gather data preoperatively, at the time of surgery, postoperatively, and in longer-term follow-up. This study has recruited 1050 participants as of September 2015 and is ongoing. This study will ensure creation of high-level evidence to enable clinicians to make meaningful evidence-based decisions for patient evaluation, selection for surgery, and follow-up care.
- 1 June 2009
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 5 (3) , 247-253
Intra/Extracellular Biosynthesis of Silver Nanoparticles by an Autochthonous Strain of Proteus mirabilis Isolated fromPhotographic Waste
There is an enormous interest in developing green synthesis procedures for production of nanoparticles by using biomimetic approaches. In our research focus has been given to the development of an efficient and eco-friendly viable process for the synthesis of nanoscale silver particles using Proteus mirabilis PTCC 1710, a bacterial strain that was isolated during a screening program from photographic waste. A significant result of this study is our observation that silver nanoparticles could be induced to synthesis intra and extracellulary. The silver nanoparticles were characterized by means of UV–Vis spectroscopy, transmission electron microscopy (TEM), energy–dispersive spectroscopy (EDS) and atomic absorption spectrometer (AAS). The nanoparticles exhibited maximum absorbance at 400–410 nm in UV–Vis spectroscopy. TEM images showed formation of stable silver nanoparticles of spherical shape with most of the particles in the size range of 10–20 nm. It was found that incubation of bacterial cells in Muller-Hinton broth medium resulted in higher extracellular synthesis of silver nanoparticles, whereas intracellular synthesis of silver nanoparticles effectively increased in tryptic soy broth. The method of extraction of intracellular silver nanoparticles was inexpensive, simple and effective in large scale with no need to complex instruments. The bacteria work as a bionanofactory which continued to grow after synthesis of silver nanoparticles. The silver reduction by this strain is occurred through energy-dependent processes that lead to the high output of this reaction. Hence this newapproach of using a non-pathogenic bacterial strain for the successful synthesis of nanosized silvers could be easily scaled up which establishes its commercial viability.
- 1 June 2009
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 5 (3) , 247-253
Intra/Extracellular Biosynthesis of Silver Nanoparticles by an Autochthonous Strain of Proteus mirabilis Isolated fromPhotographic Waste
There is an enormous interest in developing green synthesis procedures for production of nanoparticles by using biomimetic approaches. In our research focus has been given to the development of an efficient and eco-friendly viable process for the synthesis of nanoscale silver particles using Proteus mirabilis PTCC 1710, a bacterial strain that was isolated during a screening program from photographic waste. A significant result of this study is our observation that silver nanoparticles could be induced to synthesis intra and extracellulary. The silver nanoparticles were characterized by means of UV–Vis spectroscopy, transmission electron microscopy (TEM), energy–dispersive spectroscopy (EDS) and atomic absorption spectrometer (AAS). The nanoparticles exhibited maximum absorbance at 400–410 nm in UV–Vis spectroscopy. TEM images showed formation of stable silver nanoparticles of spherical shape with most of the particles in the size range of 10–20 nm. It was found that incubation of bacterial cells in Muller-Hinton broth medium resulted in higher extracellular synthesis of silver nanoparticles, whereas intracellular synthesis of silver nanoparticles effectively increased in tryptic soy broth. The method of extraction of intracellular silver nanoparticles was inexpensive, simple and effective in large scale with no need to complex instruments. The bacteria work as a bionanofactory which continued to grow after synthesis of silver nanoparticles. The silver reduction by this strain is occurred through energy-dependent processes that lead to the high output of this reaction. Hence this newapproach of using a non-pathogenic bacterial strain for the successful synthesis of nanosized silvers could be easily scaled up which establishes its commercial viability.